Strategies for the targeted delivery of therapeutics for osteosarcoma

Dennis P M Hughes1

  • 1The Children's Cancer Hospital at MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 853, Houston, TX 77030, USA. dphughes@mdanderson.org

Abstract

Insights

New osteosarcoma therapies beyond conventional methods are needed. Exploring alternative drug delivery routes and targeted treatments shows promise for improving patient outcomes and limb salvage rates.

Area of Science:

  • Oncology
  • Skeletal System Neoplasms
  • Pharmacology

Background:

  • Conventional osteosarcoma treatment survival rates have plateaued at 60-70% for two decades.
  • There is a critical need for novel therapeutic strategies to improve patient outcomes.

Purpose of the Study:

  • To explore alternative therapeutic approaches for osteosarcoma.
  • To investigate treatment delivery methods beyond central venous catheters.

Main Methods:

  • Review of the last two decades of literature on sarcoma therapy.
  • Incorporation of author's clinical experience with high-risk osteosarcoma patients.
  • Summary of potential treatments using less conventional delivery routes.

Main Results:

  • Intra-arterial chemotherapy offers limited survival benefits but may improve limb salvage.
  • Intrapleural chemotherapy is effective for managing malignant effusions.

Conclusions:

  • Inhalation therapies, bisphosphonates targeting bone formation, targeted radiation, and antibody-based treatments show potential.
  • Further research into novel therapeutic avenues is warranted for osteosarcoma management.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...